Work schedule, sleep duration, insomnia, and risk of fatal prostate cancer.

[1]  J. Siemiatycki,et al.  Night work and the risk of cancer among men. , 2012, American journal of epidemiology.

[2]  Jennifer R. Rider,et al.  Circadian Disruption, Sleep Loss, and Prostate Cancer Risk: A Systematic Review of Epidemiologic Studies , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[3]  J. Borjigin,et al.  Circadian regulation of pineal gland rhythmicity , 2012, Molecular and Cellular Endocrinology.

[4]  H. Mukhtar,et al.  Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model , 2010, Journal of pineal research.

[5]  Monique H W Frings-Dresen,et al.  Considerations of circadian impact for defining ‘shift work’ in cancer studies: IARC Working Group Report , 2010, Occupational and Environmental Medicine.

[6]  R. Stevens,et al.  Shift work and cancer - considerations on rationale, mechanisms, and epidemiology. , 2010, Scandinavian journal of work, environment & health.

[7]  D. Blask,et al.  Melatonin, sleep disturbance and cancer risk. , 2009, Sleep medicine reviews.

[8]  I. Kloog,et al.  Global Co‐Distribution of Light at Night (LAN) and Cancers of Prostate, Colon, and Lung in Men , 2009, Chronobiology international.

[9]  S. Kuriyama,et al.  Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study , 2008, British Journal of Cancer.

[10]  Terence M. McMenamin.  A Time to Work: Recent Trends in Shift Work and Flexible Schedules , 2007 .

[11]  Kurt Straif,et al.  Carcinogenicity of shift-work, painting, and fire-fighting. , 2007, The Lancet. Oncology.

[12]  Yoshiyuki Watanabe,et al.  Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. , 2006, American journal of epidemiology.

[13]  Paul J Rathouz,et al.  Objectively measured sleep characteristics among early-middle-aged adults: the CARDIA study. , 2006, American journal of epidemiology.

[14]  R. Reiter,et al.  Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism , 2005, The Prostate.

[15]  L. Fu,et al.  The circadian clock: pacemaker and tumour suppressor , 2003, Nature Reviews Cancer.

[16]  D. Kripke,et al.  Mortality associated with sleep duration and insomnia. , 2002, Archives of general psychiatry.

[17]  L. Garfinkel.  Selection, follow-up, and analysis in the American Cancer Society prospective studies. , 1985, National Cancer Institute monograph.

[18]  M. Lippman,et al.  Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. , 1982, Science.

[19]  K. Kupka.  International classification of diseases: ninth revision. , 1978, WHO chronicle.

[20]  J. Wactawski‐Wende,et al.  Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women's Health Initiative. , 2013, American journal of epidemiology.

[21]  J. DiSantostefano,et al.  International Classification of Diseases 10th Revision (ICD-10) , 2009 .

[22]  N. Lightfoot,et al.  Rotating shift work and risk of prostate cancer. , 2007, Epidemiology.

[23]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .